Rationale and design of ePPOP-ID: a multicenter randomized controlled trial using an electronic-personalized program for obesity in pregnancy to improve delivery


Ressource 1Download: Deruelle 2020 ePPOP.pdf (1011.06 [Ko])
State: Public
Version: Final published version
License: CC BY 4.0
Serval ID
Article: article from journal or magazin.
Rationale and design of ePPOP-ID: a multicenter randomized controlled trial using an electronic-personalized program for obesity in pregnancy to improve delivery
BMC pregnancy and childbirth
Deruelle Philippe, Lelorain Sophie, Deghilage Sylvie, Couturier Emmanuelle, Guilbert Elodie, Berveiller Paul, Sénat Marie Victoire, Vayssière Christophe, Sentilhes Loïc, Perrotin Franck, Gallot Denis, Chauleur Céline, Sananes Nicolas, Roth Emmanuel, Luton Dominique, Caputo Marie, Lorio Elodie, Chatelet Carla, Couster Julien, Timbely Oumar, Doret-Dion Muriel, Duhamel Alain, Pigeyre Marie
Publication state
Issued date
BACKGROUND: Pre-pregnancy obesity and excessive gestational weight gain (GWG) are established risk factors for adverse pregnancy, delivery and birth outcomes. Pregnancy is an ideal moment for nutritional interventions in order to establish healthier lifestyle behaviors in women at high risk of obstetric and neonatal complications.
METHODS: Electronic-Personalized Program for Obesity during Pregnancy to Improve Delivery (ePPOP-ID) is an open multicenter randomized controlled trial which will assess the efficacy of an e-health web-based platform offering a personalized lifestyle program to obese pregnant women in order to reduce the rate of labor procedures and delivery interventions in comparison to standard care. A total of 860 eligible pregnant women will be recruited in 18 centers in France between 12 and 22 weeks of gestation, randomized into the intervention or the control arm and followed until 10 weeks of postpartum. The intervention is based on nutrition, eating behavior, physical activity, motivation and well-being advices in which personalization is central, as well as the use of a mobile/tablet application. Inputs includes data from the medical record of participants (medical history, anthropometric data), from the web platform (questionnaires on dietary habits, eating behavior, physical activity and motivation in both groups), and adherence to the program (time of connection for the intervention group only). Data are collected at inclusion, 32 weeks, delivery and 10 weeks postpartum. As primary outcome, we will use a composite endpoint score of obstetrical interventions during labor and delivery, defined as caesarean section and instrumental delivery (forceps and vacuum extractor). Secondary outcomes will consist of data routinely collected as part of usual antenatal and perinatal care, such as GWG, hypertension, preeclampsia, as well as fetal and neonatal outcomes including premature birth, gestational age at birth, birth weight, macrosomia, Apgar score, arterial umbilical cord pH, neonatal traumatism, hyperbilirubinemia, respiratory distress syndrome, transfer in neonatal intensive care unit, and neonatal adiposity. Post-natal outcomes will be duration of breastfeeding, maternal weight retention and child weight at postnatal visit.
DISCUSSION: The findings of the ePPOP-ID trial will help design e-health intervention program for obese women in pregnancy.
TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT02924636 / October 5th 2016.
Adult, Apgar Score, Birth Weight, Cesarean delivery, Cesarean Section, Extraction, Obstetrical, Female, Fetus, Follow-Up Studies, Gestational Weight Gain, Healthy Lifestyle, Humans, Infant, Newborn, Instrumental delivery, Internet-Based Intervention, Macrosomia, Multicenter Studies as Topic, Nutrition, Obesity, Obesity, Maternal, Obstetric Labor Complications, Patient Compliance, Physical activity, Postnatal Care, Postpartum Period, Pregnancy, Prenatal Care, Randomized Controlled Trials as Topic, Risk Factors, Risk Reduction Behavior, Treatment Outcome
Create date
10/08/2022 11:49
Last modification date
02/11/2023 15:55
Usage data